{"abstract":"The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2018/03/13/2018-04996.html","cfr_references":[],"citation":"83 FR 10855","comment_url":null,"comments_close_on":"2018-04-12","correction_of":null,"corrections":[],"dates":"Submit either electronic or written comments on the collection of information by April 12, 2018.","disposition_notes":null,"docket_ids":["Docket No. FDA-2017-N-0493"],"dockets":[{"supporting_documents":[{"title":"Reference 12 NONRESPONSE RATES AND NONRESPONSE BIAS IN HOUSEHOLD SURVEYS re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0011"},{"title":"Reference 11 Explaining Rising Nonresponse Rates in Cross-Sectional Surveys re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0010"},{"title":"Reference 10 NCHS report 2016 re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0009"},{"title":"Reference 9 Effect of Framing as Gain versus Loss on Understanding and Hypothetical Treatment Choices: Survival and Mortality Curves re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among","document_id":"FDA-2017-N-0493-0008"},{"title":"Reference 8 Shaping Perceptions to Motivate Healthy Behavior: The Role of Message Framing re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0007"},{"title":"Reference 6 Important Safety Information or Important Risk Information? A Question of Framing in Prescription Drug Advertisements re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Lo","document_id":"FDA-2017-N-0493-0006"},{"title":"Reference 5 Source Selection in Prescription Drug Information Seeking and Influencing Factors: Applying the Comprehensive Model of Information Seeking in an American Context re Agency Information Collection Activities; Proposed Collection; Comment Request","document_id":"FDA-2017-N-0493-0005"},{"title":"Reference 4 How Internet users decide what information to trust when they or their loved ones are sick re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0004"},{"title":"Reference 3 Computer and Internet Use in the United States 2013 re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0003"},{"title":"Reference 1 Guidance for Industry Consumer-Directed Broadcast Advertisements re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0002"}],"agency_name":"FDA","documents":[{"comment_count":8,"comment_start_date":"2018-03-13","updated_at":"2023-02-28T15:02:35.983-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2017-N-0493-0015","allow_late_comments":null,"id":"FDA-2017-N-0493-0015","comment_end_date":"2018-04-13","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":10,"id":"FDA-2017-N-0493","title":"Utilization of Adequate Provision among Low to Non-Internet Users"}],"document_number":"2018-04996","effective_on":null,"end_page":10862,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2018/03/13/2018-04996.xml","html_url":"https://www.federalregister.gov/documents/2018/03/13/2018-04996/agency-information-collection-activities-submission-for-office-of-management-and-budget-review","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2018-04996?publication_date=2018-03-13","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2018-03-13/2018-04996/mods.xml","not_received_for_publication":null,"page_length":8,"page_views":{"count":293,"last_updated":"2026-04-04 14:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2018-03-13/pdf/2018-04996.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2018-04996.pdf?1520858723","publication_date":"2018-03-13","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2018/03/13/2018-04996.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Reference 12 NONRESPONSE RATES AND NONRESPONSE BIAS IN HOUSEHOLD SURVEYS re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0011"},{"title":"Reference 11 Explaining Rising Nonresponse Rates in Cross-Sectional Surveys re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0010"},{"title":"Reference 10 NCHS report 2016 re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0009"},{"title":"Reference 9 Effect of Framing as Gain versus Loss on Understanding and Hypothetical Treatment Choices: Survival and Mortality Curves re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among","document_id":"FDA-2017-N-0493-0008"},{"title":"Reference 8 Shaping Perceptions to Motivate Healthy Behavior: The Role of Message Framing re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0007"},{"title":"Reference 6 Important Safety Information or Important Risk Information? A Question of Framing in Prescription Drug Advertisements re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Lo","document_id":"FDA-2017-N-0493-0006"},{"title":"Reference 5 Source Selection in Prescription Drug Information Seeking and Influencing Factors: Applying the Comprehensive Model of Information Seeking in an American Context re Agency Information Collection Activities; Proposed Collection; Comment Request","document_id":"FDA-2017-N-0493-0005"},{"title":"Reference 4 How Internet users decide what information to trust when they or their loved ones are sick re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0004"},{"title":"Reference 3 Computer and Internet Use in the United States 2013 re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0003"},{"title":"Reference 1 Guidance for Industry Consumer-Directed Broadcast Advertisements re Agency Information Collection Activities; Proposed Collection; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","document_id":"FDA-2017-N-0493-0002"}],"comments_count":8,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2017-N-0493","supporting_documents_count":10,"docket_id":"FDA-2017-N-0493","document_id":"FDA-2017-N-0493-0015","regulation_id_number":null,"title":"Utilization of Adequate Provision among Low to Non-Internet Users","checked_regulationsdotgov_at":"2023-02-28T20:02:35Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":10855,"subtype":null,"title":"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users","toc_doc":"Utilization of Adequate Provision Among Low to Non-Internet Users","toc_subject":"Agency Information Collection Activities; Proposals, Submissions, and Approvals:","topics":[],"type":"Notice","volume":83}